Business, energy, technology, markets and global industry news from Business News Today

Precision Pathology Laboratory Services

PharmaDeviceNews Precision Pathology Laboratory Services
Editorial infographic highlighting bioAffinity Technologies’ $4 million financing and growing CyPath Lung sales, featuring lung diagnostic imagery, laboratory equipment and financial graphics illustrating shareholder dilution, cash runway and commercial expansion.
Medical Devices & Diagnostics

What bioAffinity Technologies’ $4m financing means for CyPath Lung growth

bioAffinity Technologies closes $4 million financing as CyPath Lung sales grow. Examine dilution, cash runway and commercial expansion.

Read More
A clinician reviews a lung scan as bioAffinity Technologies advances the CyPath Lung clinical framework for pulmonary nodule risk stratification and early lung cancer detection. Representative image.
Medical Devices & Diagnostics

How could CyPath Lung fit into pulmonary nodule evaluation after low-dose CT screening?

bioAffinity’s CyPath Lung framework targets pulmonary nodule decisions, but adoption still depends on prospective validation and payer support.

Read More
Medical Devices & Diagnostics

Can CyPath Lung sales growth turn bioAffinity Technologies into a viable diagnostics company?

Discover how bioAffinity Technologies’ CyPath Lung test is gaining physician adoption while clinical, reimbursement and funding risks remain.

Read More